The generation of influenza outbreaks by a network of host immune responses against a limited set of antigenic types

It is commonly believed that influenza epidemics arise through the incremental accumulation of viral mutations, culminating in a novel antigenic type that is able to escape host immunity. Successive epidemic strains therefore become increasingly antigenically distant from a founding strain. Here, we present an alternative explanation where, because of functional constraints on the defining epitopes, the virus population is characterized by a limited set of antigenic types, all of which may be continuously generated by mutation from preexisting strains and other processes. Under these circumstances, influenza outbreaks arise as a consequence of host immune selection in a manner that is independent of the mode and tempo of viral mutation. By contrast with existing paradigms, antigenic distance between epidemic strains does not necessarily accumulate with time in our model, and it is the changing profile of host population immunity that creates the conditions for the emergence of the next influenza strain rather than the mutational capabilities of the virus.

[1]  N. Ferguson,et al.  Chaos, persistence, and evolution of strain structure in antigenically diverse infectious agents. , 1998, Science.

[2]  Philippe Buchy,et al.  Low Frequency of Poultry-to-Human H5N1 Transmission, Southern Cambodia, 2005 , 2006, Emerging infectious diseases.

[3]  Bryan T Grenfell,et al.  Dynamics and selection of many-strain pathogens , 2002, Proceedings of the National Academy of Sciences of the United States of America.

[4]  J. Davies,et al.  Infection with influenza A H1N1: 2. The effect of past experience on natural challenge , 1986, Journal of Hygiene.

[5]  Jonathan Dushoff,et al.  Hemagglutinin sequence clusters and the antigenic evolution of influenza A virus , 2002, Proceedings of the National Academy of Sciences of the United States of America.

[6]  W. Dowdle,et al.  Influenza: its antigenic variation and ecology. , 1976, Bulletin of the Pan American Health Organization.

[7]  G. Nabel,et al.  Protection against multiple influenza A subtypes by vaccination with highly conserved nucleoprotein. , 2005, Vaccine.

[8]  Y. Guan,et al.  Establishment of multiple sublineages of H5N1 influenza virus in Asia: implications for pandemic control. , 2006, Proceedings of the National Academy of Sciences of the United States of America.

[9]  J. Taubenberger,et al.  Pathogenicity and immunogenicity of influenza viruses with genes from the 1918 pandemic virus. , 2004, Proceedings of the National Academy of Sciences of the United States of America.

[10]  A. Lapedes,et al.  Mapping the Antigenic and Genetic Evolution of Influenza Virus , 2004, Science.

[11]  N. Cox,et al.  Molecular epidemiology of influenza A(H3N2) virus reinfections. , 2002, The Journal of infectious diseases.

[12]  Angus Nicoll,et al.  Avian influenza A (H5N1) infection in humans. , 2005, The New England journal of medicine.

[13]  A. Vincent,et al.  Evaluation of hemagglutinin subtype 1 swine influenza viruses from the United States. , 2006, Veterinary microbiology.

[14]  Simon A. Levin,et al.  The dynamics of cocirculating influenza strains conferring partial cross-immunity , 1997, Journal of mathematical biology.

[15]  N. Ferguson,et al.  Ecological and immunological determinants of influenza evolution , 2003, Nature.

[16]  W. Fitch,et al.  Long term trends in the evolution of H(3) HA1 human influenza type A. , 1997, Proceedings of the National Academy of Sciences of the United States of America.

[17]  Graham F Medley,et al.  On the determinants of population structure in antigenically diverse pathogens , 2002, Proceedings of the Royal Society of London. Series B: Biological Sciences.

[18]  V. Hinshaw,et al.  Neutralizing epitopes of the H5 hemagglutinin from a virulent avian influenza virus and their relationship to pathogenicity , 1989, Journal of virology.

[19]  Elizabeth C. Theil,et al.  Epochal Evolution Shapes the Phylodynamics of Interpandemic Influenza A (H3N2) in Humans , 2006, Science.

[20]  Julia R Gog,et al.  Influenza drift and epidemic size: the race between generating and escaping immunity. , 2004, Theoretical population biology.

[21]  R. Webster,et al.  Cross-protectiveness and immunogenicity of influenza A/Duck/Singapore/3/97(H5) vaccines against infection with A/Vietnam/1203/04(H5N1) virus in ferrets. , 2006, The Journal of infectious diseases.

[22]  N L Kaplan,et al.  The coalescent process in models with selection. , 1988, Genetics.

[23]  Alex S. Morton,et al.  Modelling antigenic drift in weekly flu incidence , 2005, Statistics in medicine.

[24]  W. Fitch,et al.  Predicting the evolution of human influenza A. , 1999, Science.

[25]  Edward C Holmes,et al.  Error thresholds and the constraints to RNA virus evolution , 2003, Trends in Microbiology.

[26]  A. Sasaki,et al.  Evolutionary pattern of intra-host pathogen antigenic drift: effect of cross-reactivity in immune response. , 1997, Philosophical transactions of the Royal Society of London. Series B, Biological sciences.

[27]  William Ho,et al.  Risk of influenza A (H5N1) infection among health care workers exposed to patients with influenza A (H5N1), Hong Kong. , 2000, The Journal of infectious diseases.

[28]  N. Cox,et al.  Cross-protective immunity in mice induced by live-attenuated or inactivated vaccines against highly pathogenic influenza A (H5N1) viruses. , 2006, Vaccine.

[29]  N L Kaplan,et al.  The "hitchhiking effect" revisited. , 1989, Genetics.

[30]  R. Webster,et al.  Influenza virus subunit vaccines. II. Immunogenicity and original antigenic sin in humans. , 1976, The Journal of infectious diseases.

[31]  Bryan T Grenfell,et al.  Whole-Genome Analysis of Human Influenza A Virus Reveals Multiple Persistent Lineages and Reassortment among Recent H3N2 Viruses , 2005, PLoS biology.

[32]  R. Webster,et al.  Structure of antigenic sites on the haemagglutinin molecule of H5 avian influenza virus and phenotypic variation of escape mutants. , 2002, The Journal of general virology.